✦ LIBER ✦

Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease

✍ Scribed by T. Aomatsu; H. Imaeda; K. Matsumoto; E. Kimura; A. Yoden; H. Tamai; Y. Fujiyama; E. Mizoguchi; A. Andoh

Book ID: 108606424
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 337 KB
Volume: 34
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2011.04805.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot study using PET/CT as a novel, non

Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease

✍ Randall S. Meisner; Bret J. Spier; Sigurdur Einarsson; Erica N. Roberson; Scott 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Background: A pilot study was performed investigating the possibility that positron emission tomography (PET) activity using 18-fluorodeoxyglucose (FDG) with nearly simultaneous computerized tomography (CT) for anatomic accuracy would identify regions of active inflammation in both ulcerative coliti

Increased levels of serum pentraxin 3, a

Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease

✍ Ivana Hollan; Barbara Bottazzi; Ivan Cuccovillo; Øystein T. Førre; Knut Mikkelse 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 143 KB 👁 2 views

## Abstract ## Objective Pentraxin 3 (PTX3), a key component of innate immunity, is a strong marker of disease severity in coronary artery disease (CAD). The aim of this study was to compare levels of serum PTX3 in CAD patients with and without inflammatory rheumatic disease (IRD) and in healthy c

Serum α1-antitrypsin levels as a marker

Serum α1-antitrypsin levels as a marker of activity in pediatric inflammatory bowel disease

✍ Dr. Michael J. Pettei; Jeremiah J. Levine 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

The purpose of this study was to evaluate the use of the acute-phase serum protein a,-antitrypsin (a,- AT) compared with the erythrocyte sedimentation rate (ESR), platelet count, and hemoglobin level in screening for inflammation in newly diagnosed and known patients with inflammatory bowel disease

Sialic acid–binding Ig-like lectin 1 exp

Sialic acid–binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

✍ Robert Biesen; Cemal Demir; Fidan Barkhudarova; Joachim R. Grün; Marta Steinbric 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

## Abstract ## Objective Type I interferon (IFN) plays a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE) and is therefore considered a potential therapeutic target. This study was undertaken to establish a feasible biomarker for IFN effects with respect to disease activity a